Acclarent

Acclarent

New technologies to treat patients suffering from ent disorders.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
investor investor

€0.0

round
investor investor investor investor

€0.0

round
investor investor investor investor investor

€0.0

round
investor

€0.0

Valuation: €0.0

round
*

$275m

Acquisition
Total Funding000k
More about Acclarent
Made with AI
Edit

Acclarent, a subsidiary of Johnson & Johnson Medical Devices Companies, specializes in developing minimally invasive ear, nose, and throat (ENT) solutions. The company primarily serves healthcare providers, including hospitals and specialized ENT clinics, by offering advanced medical devices designed to improve patient outcomes and streamline surgical procedures. Operating within the medical device industry, Acclarent focuses on innovation and the integration of cutting-edge technology to address common ENT issues such as chronic sinusitis and Eustachian tube dysfunction. The business model revolves around the research, development, and commercialization of these specialized devices, generating revenue through the sale of its products to medical institutions and practitioners. Acclarent leverages Johnson & Johnson's extensive distribution network and expertise in medical technology to maintain a competitive edge in the market.

Keywords: ENT solutions, minimally invasive, medical devices, chronic sinusitis, Eustachian tube, healthcare providers, innovation, patient outcomes, surgical procedures, Johnson & Johnson.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Acclarent

Edit
Innovative Spinal Technologies
ACQUISITION by Integra LifeSciences Sep 2009